Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Sam Arcidiacono"'
Autor:
Genmin Lu, Pamela B. Conley, Anne M. Winkler, Vy Nguyen, Krisjela Shishko, Ryan Marett, Anuja Khan, Sam Arcidiacono, Khanh Linh Bui
Publikováno v:
Blood. 136:5-5
Background: Assay parameters for anti-FXa activity assays for apixaban and rivaroxaban on the ACL TOP/TOP 50 analyzers have been modified to minimize the effect of sample dilution suitable for analyzing andexanet-containing samples with drug-specific
Autor:
Anuja Khan, Pamela B. Conley, Krisjela Shishko, Sam Arcidiacono, Khanh Linh Bui, Anne M. Winkler, Genmin Lu
Publikováno v:
Blood. 134:1153-1153
Background: Andexanet alfa (AnXa) is a modified human FXa protein approved in the US and EU for reversal of direct factor Xa (FXa) inhibitors (apixaban, rivaroxaban) due to life-threatening or uncontrolled bleeding. AnXa reverses the anticoagulant ef
Publikováno v:
Blood. 110:3935-3935
The availability of accurate and precise Fibrinogen concentration measurements throughout low, normal and elevated ranges are of significant utility in clinical practice. The assessment of elevated fibrinogen levels is valuable as a known marker of c